Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.
Personality in multiple sclerosis (MS): impact on health, psychological well-being, coping, and overall quality of life.
Protective effects of monomethyl fumarate at the inflamed blood-brain barrier.
Phase III study with teriflunomide versus placebo in patients with first clinical symptom of multiple sclerosis (TOPIC)
Reversible cerebral vasoconstriction syndrome associated with interferon beta-1a use for multiple sclerosis.
Inflammation-induced fatigue: Exploring neurobiological mechanisms and potential treatments
Intermittent self-catheterisation in MS.
Neuromyelitis optica: Evaluation of 871 attacks and 1153 treatment courses.
Natalizumab treatment decreases serum IgM and IgG levels in multiple sclerosis patients.
Randomized controlled trial of interferon-beta-1a in secondary progressive MS: MRI results.
Pharmacology and therapeutic potential of interferons.
Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis.
Dilantin
Immune mechanisms of new therapeutic strategies in multiple sclerosis-A focus on alemtuzumab.
Safety Study of Interferon Beta-1a for Acute Stroke
Rituximab versus fingolimod after natalizumab in multiple sclerosis patients.
Diffusely abnormal white matter in multiple sclerosis: further histologic studies provide evidence for a primary lipid abnormality with neurodegeneration.
Acorda Therapeutics announces initiation of AMPYRA® proof-of-concept study in patients with post-stroke deficits
Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis.
Interferon β-1b directly modulates human neural stem/progenitor cell fate.
Necrotizing skin lesion and radial nerve palsy in a patient treated with glatiramer acetate.
The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research.
Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder.
Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients.
Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine.

Pages